Cargando…
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders
Autores principales: | Andrews, Christopher N, Devlin, Shane M, Le Foll, Bernard, Fischer, Benedikt, Tse, Frances, Storr, Martin, Congly, Stephen E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507278/ https://www.ncbi.nlm.nih.gov/pubmed/31294362 http://dx.doi.org/10.1093/jcag/gwy064 |
Ejemplares similares
-
Canadian Association of Gastroenterology Position Statement on the Impact of Simethicone on Endoscope Reprocessing
por: Benmassaoud, Amine, et al.
Publicado: (2018) -
Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-n-butylbromide (Buscopan) During Gastrointestinal Endoscopy
por: Forbes, Nauzer, et al.
Publicado: (2021) -
Journal of the Canadian Association of Gastroenterology
por: Marshall, John K
Publicado: (2018) -
Canadian Association of Gastroenterology Communique: After-Hours Endoscopy Cart
por: Rai, Mandip, et al.
Publicado: (2020) -
COVID-19 and Canadian Gastroenterology Trainees
por: Khan, Rishad, et al.
Publicado: (2020)